Nationality American Education Bucknell University Role Executive | Name Glen Tullman Occupation Managing Partner Organizations founded Allscripts | |
 | ||
Glen Tullman of Livongo | Bootstrapping in America
Glen E. Tullman is Chief Executive Officer of Livongo Health, a consumer digital health company. He is an American entrepreneur and investor who has built, run, and sold businesses across a range of industries. He also serves as Co-Founder and Managing Partner at 7wireVentures, a $100M venture firm that is focused on investing in healthcare firms with a focus on the "Intelligent, Connected, Health Consumer."
Contents
- Glen Tullman of Livongo Bootstrapping in America
- Early life and Education
- Career
- Awards and Recognition
- References
Previously, Tullman was CEO of Allscripts (NASDAQ: MDRX), one of the country’s largest electronic health record and health information technology companies. Tullman grew Allscripts to more than $1.4B and took the company public. Tullman also co-founded SoCore Energy, the country’s top mid-market solar commercial installer and owner, and then sold it to Edison International.
Tullman currently serves as Executive Chairman of ArgoTea, is a co-founder and board member of ZestHealth, and owns Ignite Glass Studios, a venue featuring glassblowing classes, hand-blown glass art exhibits, and space for hosting events in Chicago’s west loop neighborhood.
Glen founded a predecessor technology company, Modern Teacher, a classroom technology startup, and currently serves on the Board, and is an investor in WiserTogether, a crowd sourced healthcare information company. He is a Chancellor to the International Board of JDRF as well as a contributor to Forbes since August 2011.
Early life and Education
Tullman was born on August 12, 1959, in Highland Park, IL. He is the youngest of six children. He graduated from New Providence High School in New Providence, New Jersey in 1977.
After receiving his undergraduate degree in 1981 in economics and psychology from Bucknell University, Tullman joined the Executive Office of the President of the United States in Washington, D.C., and later accepted a Rotary Fellowship to study social anthropology at St. Antony’s College, Oxford University, England. He also completed the Delivering Information Services (DIS) program at Harvard Business School Executive Education.
Career
Prior to starting 7wireVentures with Lee Shapiro, Tullman served as Chief ExecutiveOfficer of Allscripts Healthcare Solutions (NASDAQ: MDRX).
Tullman joined Allscripts as CEO in August 1997 and he announced he would be stepping down from his CEO position at Allscripts on December 19, 2012.. He led Allscripts’ Initial Public Offering and secondary offerings of the company and in August 2010, he led the $1.3 billion merger with Eclipsys Corporation.
Previously, Tullman was CEO of Enterprise Systems, a healthcare-information services company providing resource-management solutions to large, integrated healthcare networks. Tullman led its IPO and secondary offerings before a successful sale to McKesson Corporation (then HBOC).
From 1983 to 1994, Tullman also served in a number of management roles, including president and chief operating officer of CCC Information Services, a provider of information systems to property and casualty insurers. Under his leadership, the company grew from $17 million to more than $100 million in revenue.
Tullman also founded the National ePrescribing Patient Safety Initiative (NEPSI) a coalition of technology and healthcare companies with the objective of providing free electronic prescribing to every physician in America. Today, more than 25 million prescriptions are written on the software.
Outside of work, Tullman serves as a Board Member for World Business Chicago, and was designated a Chancellor on the International Board of Directors of JDRF, where he previously served as Board Member. In May 2009, he was recognized as “Person of the Year” by the Illinois chapter of JDRF for his years of work across many areas of the JDRF organization including his early funding of the Artificial Pancreas Project, which is now far along in clinical trials, and fundraising.
He has also served as a guest lecturer at the Harvard School of Business in Boston, MA and the Wharton School of Business in Philadelphia, PA.